Business
Sale of Minority Share in Scienta Omicron
Sale of Minority Share in Scienta Omicron.
About this update from Oxford Instruments Plc
[{"type":"text","content":"\n \nRNS Number : 2202B Oxford Instruments PLC 29 January 2020 \n\n \n \n \nOxford Instruments plc\nSale of Minority Share in Scienta Omicron\n \nOxford, 29 January 2020\n \nOxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, today announces that it has completed the sale of its 47% share in Scienta Omicron to a group of existing shareholders in the joint venture for a consideration of SEK 147 million (£11.7 million).\n \nThe joint venture was established in 2015 consisting of Oxford Instruments' Omicron Nanotechnology GmBH and GDI's Scienta Scientific, creating a leading company in Ultra High Vacuum Surface Science.\n \nIan Barkshire, Chief Executive of Oxford Instruments said, \"The sale of our share in Scienta Omicron supports our continued customer-centric focus on our chosen markets with long-term growth drivers where we can maintain or develop leading positions, enhancing our ability to deliver further growth and margin improvement.\" \n \n \n \n-END-\n \nEnquiries:\n \nOxford Instruments plc Tel: 01865 393200\nIan Barkshire, Chief Executive\nGavin Hill, Group Finance Director\n \nMHP Communications Tel: 020 3128 8100\nRachel Hirst/Alice McLaren\n \n \n \n- Ends -\nIssued for and on behalf of Oxford Instruments plc\nNotes to Editors \n \nAbout Oxford Instruments plc\nOxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving f...